NZE Stock Chart & Stats
€13.40
-€0.30(-2.54%)
At close: 4:00 PM EDT
€13.40
-€0.30(-2.54%)
Day’s Range― - ―
52-Week Range€8.75 - €13.80
Previous CloseN/A
Volume0.00
Average Volume (3M)76.00
Market Cap
€2.30B
Enterprise Value€458.25B
Total Cash (Recent Filing)€40.15B
Total Debt (Recent Filing)€44.83B
Price to Earnings (P/E)10.1
Beta0.44
Next Earnings
Jan 29, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)214.94
Shares Outstanding209,251,250
10 Day Avg. Volume0
30 Day Avg. Volume76
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)0.90
Price to Sales (P/S)0.83
P/FCF Ratio20.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.19
Revenue Forecast (FY)€2.41B
Bulls Say, Bears Say
Bulls Say
Very Low LeverageZeon’s very low leverage provides financial resilience during specialty-chemical cycles and reduces the burden of interest obligations. A sizable equity base also preserves flexibility to fund operations, absorb demand volatility, and pursue growth or capital investment without relying heavily on additional borrowing.
Improved ProfitabilityThe meaningful improvement in net margin indicates that profitability recovered year over year despite a difficult operating backdrop. If maintained, stronger earnings conversion can support reinvestment, dividends, and balance-sheet resilience, while improving the economics of Zeon’s specialty and advanced materials businesses.
Positive Cash-flow ReboundThe return to positive free cash flow strengthens Zeon’s ability to internally fund working capital, investment, and shareholder distributions. Higher operating cash generation also gives the company more financial autonomy, particularly valuable in cyclical materials markets where earnings and demand can fluctuate.
Bears Say
Sharp Revenue DeclineA sharp revenue contraction signals weaker demand, pricing, mix, or volume conditions across Zeon’s materials businesses. Sustained top-line pressure can reduce operating leverage and limit the company’s ability to grow earnings, even when cost control or product mix temporarily supports margins.
Volatile Free Cash FlowRepeated swings between negative and positive free cash flow make the company’s internal funding profile less predictable. This volatility can complicate capital allocation and reduce confidence that reported earnings will consistently translate into cash available for investment, debt reduction, or distributions.
Margins Below Prior PeaksAlthough profitability improved in 2026, margins remain below earlier peak levels, suggesting that pricing, product mix, or cost conditions are not yet as favorable as before. This limits near-term earnings quality and indicates that full margin recovery may depend on improved market conditions or execution.
Zeon News
NZE FAQ
What was Zeon Corporation’s price range in the past 12 months?
Zeon Corporation lowest stock price was €8.75 and its highest was €13.80 in the past 12 months.
What is Zeon Corporation’s market cap?
Zeon Corporation’s market cap is €2.30B.
When is Zeon Corporation’s upcoming earnings report date?
Zeon Corporation’s upcoming earnings report date is Jan 29, 2027 which is in 90 days.
How were Zeon Corporation’s earnings last quarter?
Zeon Corporation released its earnings results on Oct 29, 2026. The company reported €0.401 earnings per share for the quarter.
Is Zeon Corporation overvalued?
According to Wall Street analysts Zeon Corporation’s price is currently Overvalued.
Does Zeon Corporation pay dividends?
Zeon Corporation does not currently pay dividends.
What is Zeon Corporation’s EPS estimate?
Zeon Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zeon Corporation have?
Zeon Corporation has 209,251,250 shares outstanding.
What happened to Zeon Corporation’s price movement after its last earnings report?
Zeon Corporation reported an EPS of €0.401 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Zeon Corporation?
Currently, no hedge funds are holding shares in DE:NZE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zeon Corporation
Zeon Corporation, based in Tokyo, Japan, and established in 1950, operates across diverse sectors including elastomers, specialized materials, and various other ventures. Its elastomers segment encompasses the production of synthetic rubbers, including general-purpose types utilized in automotive tires, alongside specialized rubbers such as NBR and hydrogenated NBR. The company also supplies synthetic latex varieties like styrene-butadiene copolymer latex, polybutadiene, and acrylonitrile butadiene copolymer latex, which find application in areas such as paper processing, fiber treatment, adhesives, paints, and rubber gloves. Furthermore, it produces materials for adhesive tapes, hot melt adhesives, binders for road marking paints, and additives for concrete. In specialty chemicals, Zeon provides synthetic aromatic compounds for the flavor and fragrance industries, as well as cyclopentene, cyclopentanone, and their derivatives for chemical synthesis. They also offer intermediates crucial for pharmaceuticals and agrochemicals, alongside solvents and cleaning agents. For the electronics industry, the firm offers electronic materials, components for rechargeable batteries, and toners, all essential for manufacturing semiconductors, etching gases, and battery production. Its specialty plastics range includes cyclo olefin polymers (COP) and sophisticated products derived from COP, which are employed in optical lenses, medical apparatus, and a variety of common engineering plastics. Beyond materials, Zeon is involved in the development, manufacturing, and sales of medical devices for cardiovascular and gastrointestinal health, in addition to nutritional supplements. The company also engages in technology transfer, licensing its butadiene recovery and butene purification processes to around 23 countries globally. A notable product offering is PENTAM, an energy- and resource-efficient molded item.










